See this page online at: http://www.biotechfocus.com/2007Issue5


  • Make this your homepage
  • Print this Page


Magazine

Sign up for your free subscription and keep up-to-date.


Upcoming Events


Newsletters

Stay updated on the latest news and technologies with Bioscienceworld's newsletters.
Five to choose from.


Email Address

May 2007

Volume 10 Issue 5

How can Canada survive in a globally-driven pharmaceutical market?
By Pierre Bourassa and Dr. John Lawson

Canada is a big, big country in size. Its neighbour, the USA, is 5% smaller and yet holds 10 times the population. Eighty percent of Canadians live within 200 km of the USA border, which perhaps says a lot about the attitude of Canadian economic dependence that exists.

Perspective Commercialization of genomics
By Dr. Christian Burks

One of the great expectations of genomics in the 1990s was that it would radically and directly improve the business of drug discovery. This expectation contributed to the start-up of many genomics-based biotechnology companies and the build out of genomics infrastructure in large, established biotechnology and pharmaceutical companies.

Canadian Biotech Then And Now 10 Year Retrospect
By Tonya Costoff

"Canada: Your Innovation Partner" - A strong message, and one that Industry Canada is doing its best to get out ot the international market.

British Columbia is home to the seventh largest biotechnology cluster in North America
By Tonya Costoff

British Columbia is home to the seventh largest biotechnology cluster in North America and is also the fastest growing cluster of its kind in Canada. It houses three of Canada's top five biotech companies and five of the countries top ten in terms of market cap.

Alberta is known for its foresight and taking risks to pursue technological innovation
The province's abundance of energy and natural resources create a wealth that fuels Alberta's new economy, which includes the growth in the life sciences industry.

Ontario has taken a proactive approach to biotechnology in the past 10 years
By Tonya Costoff

Ontario has taken a proactive approach to biotechnology in the past 10 years. In 1998 the province assembled a community-based Ontario Biotechnology Task Force to outline what was needed to generate a vibrant biotechnology industry in Ontario.

Over the past few years, the health industries have grown significantly in the province of Québec
By Tonya Costoff

This industry cluster now includes all the stages of new product development, from basic research to marketing, by way of pre-clinical and clinical development as well as the production stage itself.

Atlantic Canada is the country's centre for aquaculture
By Tonya Costoff

Atlantic Canada is the country's centre for aquaculture and rightfully so. It happens to be home to one of the richest and most varied natural marine environments in the world.

Taking a look at innovative biotechnology firms
By Tonya Costoff

An innovative biotechnology firm is a firm that uses biotechnology for the purpose of developing new products or processes.

Ernst & Young Beyond Borders 2007 Report Summary
By Tonya Costoff

The Canadian biotechnology industry enjoyed a banner year in 2006, according to the findings of the 2007 Ernst & Young Beyond Borders Report. Among the highlights listed in the report, Canadian biotech companies set record numbers in terms of capital raised and financing.